Cargando…

MIF Variant rs755622 Is Associated with Severe Crohn’s Disease and Better Response to Anti-TNF Adalimumab Therapy

Crohn’s disease (CD), rheumatoid arthritis, psoriatic arthritis and other inflammatory diseases comprise a group of chronic diseases with immune-mediated pathogenesis which share common pathological pathways, as well as treatment strategies including anti-TNF biologic therapy. However, the response...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jezernik, Gregor, Gorenjak, Mario, Potočnik, Uroš
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957382/ https://www.ncbi.nlm.nih.gov/pubmed/36833379 http://dx.doi.org/10.3390/genes14020452

Ejemplares similares

Omics data integration identifies ELOVL7 and MMD gene regions as novel loci for adalimumab response in patients with Crohn’s disease
por: Gorenjak, Mario, et al.
Publicado: (2021)

Gene Ontology Analysis Highlights Biological Processes Influencing Non-Response to Anti-TNF Therapy in Rheumatoid Arthritis
por: Jezernik, Gregor, et al.
Publicado: (2022)

Identification of Novel Loci Involved in Adalimumab Response in Crohn’s Disease Patients Using Integration of Genome Profiling and Isoform-Level Immune-Cell Deconvoluted Transcriptome Profiling of Colon Tissue
por: Gorenjak, Mario, et al.
Publicado: (2022)

The MIF promoter SNP rs755622 is associated with immune activation in glioblastoma
por: Alban, Tyler J., et al.
Publicado: (2023)

Association Between MIF-AS rs755622 and Nephrolithiasis Risk in a Chinese Population
por: Ma, Gaoxiang, et al.
Publicado: (2016)

MIF rs755622 and IL6 rs1800795 Are Implied in Genetic Susceptibility to End-Stage Renal Disease (ESRD)
por: Guarneri, Marco, et al.
Publicado: (2022)

Meta-Analytic Comparison of Global RNA Transcriptomes of Acute and Chronic Myeloid Leukemia Cells Reveals Novel Gene Candidates Governing Myeloid Malignancies
por: Jurgec, Staša, et al.
Publicado: (2022)

Genetic profile of MIF single nucleotide polymorphism (rs755622 G>C) in hepatocellular carcinoma among Egyptian patients
por: Osman, Heba Ahmed, et al.
Publicado: (2023)

MIF gene rs755622 polymorphism positively associated with acute coronary syndrome in Chinese Han population: case–control study
por: Du, Guo-Li, et al.
Publicado: (2020)

Association between MIF gene promoter rs755622 and susceptibility to coronary artery disease and inflammatory cytokines in the Chinese Han population
por: Luo, Jun-Yi, et al.
Publicado: (2021)

The Macrophage Migration Inhibitory Factor (MIF) Promoter Polymorphisms (rs3063368, rs755622) Predict Acute Kidney Injury and Death after Cardiac Surgery
por: Averdunk, Luisa, et al.
Publicado: (2020)

MIF -173G/C (rs755622) polymorphism modulates coronary artery disease risk: evidence from a systematic meta-analysis
por: Li, De-Yang, et al.
Publicado: (2020)

MIF Gene Polymorphism rs755622 Is Associated With Coronary Artery Disease and Severity of Coronary Lesions in a Chinese Kazakh Population: A Case–Control Study
por: Luo, Jun-Yi, et al.
Publicado: (2016)

MIF -173 G > C (rs755622) Gene Polymorphism Modulates Tuberculosis Risk: Evidence from a Meta-analysis and Trial Sequential Analysis
por: Areeshi, Mohammed Y., et al.
Publicado: (2017)

Gene Ontology Analysis Highlights Biological Processes Influencing Responsiveness to Biological Therapy in Psoriasis
por: Krušič, Martina, et al.
Publicado: (2023)

MFUM-BrTNBC-1, a Newly Established Patient-Derived Triple-Negative Breast Cancer Cell Line: Molecular Characterisation, Genetic Stability, and Comprehensive Comparison with Commercial Breast Cancer Cell Lines
por: Skok, Kristijan, et al.
Publicado: (2021)

Molecular Genetic Architecture of Monogenic Pediatric IBD Differs from Complex Pediatric and Adult IBD
por: Jezernik, Gregor, et al.
Publicado: (2020)

Genetic Variant rs755622 Regulates Expression of the Multiple Sclerosis Severity Modifier D-Dopachrome Tautomerase in a Sex-Specific Way
por: Han, Zhijie, et al.
Publicado: (2018)

De novo mutation in KITLG gene causes a variant of Familial Progressive Hyper‐ and Hypo‐pigmentation (FPHH)
por: Gorenjak, Mario, et al.
Publicado: (2021)

Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?
por: Im, Jong Pil
Publicado: (2017)

Dysregulation of Synaptic Signaling Genes Is Involved in Biology of Uterine Leiomyoma
por: Krsteski, Jovan, et al.
Publicado: (2021)

Dermatofibrosarcoma Protuberans (DFSP) with Fibrosarcomatous Changes in a Patient with Crohn's Disease Treated with Anti-TNF (Adalimumab)
por: Klarin, Ivo
Publicado: (2023)

Pre-Treatment Biomarkers of Anti-Tumour Necrosis Factor Therapy Response in Crohn’s Disease—A Systematic Review and Gene Ontology Analysis
por: Gole, Boris, et al.
Publicado: (2019)

Adalimumab in Crohn’s disease
por: Van Assche, Gert, et al.
Publicado: (2007)

Cholecalciferol Supplementation Induced Up-Regulation of SARAF Gene and Down-Regulated miR-155-5p Expression in Slovenian Patients with Multiple Sclerosis
por: Gselman, Saša, et al.
Publicado: (2023)

Transcriptomics of receptive endometrium in women with sonographic features of adenomyosis
por: Prašnikar, Erika, et al.
Publicado: (2022)

Adalimumab for the treatment of Crohn’s disease
por: Cassinotti, Andrea, et al.
Publicado: (2008)

Anti–NMDAR encephalitis in a patient with Crohn disease receiving adalimumab
por: Noble, Geoffrey P., et al.
Publicado: (2018)

Macrophage migration inhibitory factor gene rs755622 G/C polymorphism and coronary artery disease: A meta-analysis of 8,488 participants
por: Li, Yan-yan, et al.
Publicado: (2022)

Anti-TNF Therapy in Crohn’s Disease
por: Adegbola, Samuel O., et al.
Publicado: (2018)

Adalimumab Therapy Improves Intestinal Dysbiosis in Crohn’s Disease
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2019)

Adalimumab for the treatment of fistulas in patients with Crohn’s disease
por: Colombel, J-F, et al.
Publicado: (2009)

Management of Crohn’s disease in poor responders to adalimumab
por: de Boer, Nanne KH, et al.
Publicado: (2014)

Efficacy of Adalimumab in Korean Patients with Crohn’s Disease
por: Sohn, Il Woong, et al.
Publicado: (2016)

Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease
por: Chaparro, María, et al.
Publicado: (2019)

Anti-therapeutic antibodies and their clinical impact in patients treated with the TNF antagonist adalimumab
por: Cludts, Isabelle, et al.
Publicado: (2017)

Pharmacogenetic Analysis of the MIR146A rs2910164 and MIR155 rs767649 Polymorphisms and Response to Anti-TNF Treatment in Patients with Crohn’s Disease and Psoriasis
por: Nani, Paraskevi, et al.
Publicado: (2023)

Association of the genetic variants (‐794 CATT5‐8 and ‐173 G > C) of macrophage migration inhibitory factor (MIF) with higher soluble levels of MIF and TNFα in women with breast cancer
por: Avalos‐Navarro, Guadalupe, et al.
Publicado: (2020)

A Meta-Analysis of Adalimumab for Fistula in Crohn's Disease
por: Fu, Yin-mei, et al.
Publicado: (2017)

Difficult-to-treat-pediatric Crohn’s disease: focus on adalimumab
por: Zeisler, Bella, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f9ktkp5ehf292j4adii3pnbhba